abstract |
Use of a biomarker in the preparation or screening of a liver cancer diagnostic reagent, the biomarker comprising at least one of the following genes: anxa1, Anxa4, CD90, Gpc3, Ccnd2, Afp. The biomarker provided by the invention can effectively predict the prognosis of a patient and provide a basis for further treatment. |